Patents by Inventor Rafael Cordero
Rafael Cordero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240130776Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: ApplicationFiled: October 24, 2019Publication date: April 25, 2024Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Patent number: 11963709Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: GrantFiled: October 25, 2019Date of Patent: April 23, 2024Assignee: CSA Medical, Inc.Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Publication number: 20230247984Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.Type: ApplicationFiled: April 7, 2023Publication date: August 10, 2023Applicant: Hemanext Inc.Inventors: Michael WOLF, Jancarlo SARITA, Jeffrey Karl SUTTON, Rafael CORDERO, Michael ZOCCHI, Philip KEEGAN, Narendran RENGANATHAN, Robert HARHEN
-
Patent number: 11638421Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.Type: GrantFiled: May 20, 2022Date of Patent: May 2, 2023Assignee: Hemanext Inc.Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
-
Publication number: 20230131453Abstract: A cardiac defibrillation system. The system comprising a housing and an implantable lead. The implantable lead comprising two ends, including a first end connected to the housing and a second end being a free end. The implantable lead also comprising a defibrillation electrode and at least three detection electrodes including a first detection electrode, a second detection electrode, and a third detection electrode. The first detection electrode and the second detection electrode forming a first dipole. The third detection electrode and the first detection electrode, or, the third detection electrode and the second detection electrode, or, the housing and one of said detection electrodes, forming a second dipole, where a length of the first dipole is between 5 and 50 millimeters and a length of the second dipole is between 50 and 400 millimeters.Type: ApplicationFiled: December 22, 2022Publication date: April 27, 2023Applicant: SORIN CRM SASInventors: Thierry Legay, Rafael Cordero Alvarez, Delphine Feuerstein
-
Publication number: 20230047634Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.Type: ApplicationFiled: October 28, 2022Publication date: February 16, 2023Applicant: Hemanext Inc.Inventors: Angelo D'ALESSANDRO, Rafael CORDERO, Andrew DUNHAM, Philip KEEGAN, Tatsuro YOSHIDA
-
Patent number: 11541246Abstract: The present invention relates to a medical device, in particular to an implantable medical device, comprising at least one implantable or non-implantable hemodynamic sensor configured for detecting hemodynamic cardiac signals, a controller configured for processing and analyzing the detected cardiac hemodynamic signals or signals derived from the detected cardiac hemodynamic signals by applying to said signals a Teager Energy Operator (TEO). The controller further comprises at least one algorithm configured to determine the need for a defibrillation operation by taking into account the at least one output hemodynamic signal. The present invention also provides a method and software for detecting or treating a ventricular fibrillation episode by taking into account cardiac hemodynamic signals.Type: GrantFiled: December 19, 2019Date of Patent: January 3, 2023Assignee: Sorin CRM SASInventors: Rafael Cordero Alvarez, Delphine Feuerstein
-
Patent number: 11534616Abstract: A subcutaneous cardiac defibrillation system implantable comprising a housing and a subcutaneous implantable lead comprising a proximal end connected to the housing and a distal free end. The subcutaneous implantable lead comprises at least one defibrillation electrode and at least three detection electrodes. The first detection electrode and the second detection electrode form a first dipole, and the third detection electrode and the first detection electrode, or the third detection electrode and the second detection electrode, or the housing and one of said detection electrodes, form a second dipole. The defibrillation electrode is positioned between the second detection electrode and the third detection electrode, the first dipole is positioned between the housing and the defibrillation electrode, the third electrode is positioned between the free distal end of the lead and the defibrillation electrode, and the length of the first dipole is shorter than the length of the second dipole.Type: GrantFiled: July 2, 2020Date of Patent: December 27, 2022Assignee: Sorin CRM SASInventors: Thierry Legay, Rafael Cordero Alvarez, Delphine Feuerstein
-
Patent number: 11478290Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: GrantFiled: August 11, 2020Date of Patent: October 25, 2022Assignee: CSA Medical, Inc.Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Publication number: 20220287296Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.Type: ApplicationFiled: May 20, 2022Publication date: September 15, 2022Applicant: Hemanext Inc.Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
-
Patent number: 11375709Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.Type: GrantFiled: April 4, 2019Date of Patent: July 5, 2022Assignee: Hemanext Inc.Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
-
Patent number: 11350626Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.Type: GrantFiled: August 2, 2018Date of Patent: June 7, 2022Assignee: Hemanext Inc.Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
-
Patent number: 11090331Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology. Methods for reducing the risk of an inflammatory response in a sickle cell patient in need of a blood transfusion.Type: GrantFiled: May 15, 2020Date of Patent: August 17, 2021Assignee: Hemanext Inc.Inventors: Angelo D'Alessandro, Rafael Cordero, Andrew Dunham, Philip Keegan, Tatsuro Yoshida
-
Publication number: 20210100721Abstract: A blood storage container for the anaerobic storage of blood, having enhanced sealing methods and materials for the preservation of stored blood is provided.Type: ApplicationFiled: October 16, 2020Publication date: April 8, 2021Applicant: Hemanext Inc.Inventors: Tatsuro YOSHIDA, Rafael CORDERO, Jancarlo SARITA, Michael ZOCCHI, Michael WOLF, Philip Michael KEEGAN, Narendran RENGANATHAN, Jeffrey Karl SUTTON
-
Publication number: 20210029974Abstract: An aquaculture pen includes an annular floatation assembly formed from a plurality of float platforms connected end to end. A weight ring is suspended from the floatation assembly by a first plurality of tension members at a central portion of the float platforms. A net support ring is suspended from the floatation assembly by a second plurality of tension members that are attached to the floatation assembly, for example, outboard of the first plurality of tension members. A mesh enclosure for the pen includes a main portion attached to the net support ring, a jump net portion that extends from the net support ring to engage the inboard side of the floatation assembly, and a top portion that closes an upper end of the mesh enclosure.Type: ApplicationFiled: July 29, 2020Publication date: February 4, 2021Applicant: InnovaSea Systems, Inc.Inventors: Mark Penner, David P. Kelly, Peter Nicholas Woskov, Harrison P. Zimmer, Jeffrey Reifsnyder, Rafael Cordero, Wyatt Grass, James Fitzgerald, Todd Vangsness, Matthew Darres
-
Publication number: 20210001136Abstract: A subcutaneous implantable active medical device, in particular a subcutaneous cardiac defibrillator, comprising a housing and a subcutaneous implantable lead connected to the housing. The subcutaneous implantable lead comprises a plurality of sensing electrodes forming at least two dipoles from which at least two electrical signals are collected concurrently. The first dipole having a first length less than a second length of the second dipole. The subcutaneous implantable active medical device further comprises a controller configured to determine whether or not tachyarrhythmia is present by determining a criterion of similarity based on the electrical signals collected concurrently via the first dipole and via the second dipole during a defined series of cardiac cycles that is such that detection of a depolarization peak, corresponding to detection of an R wave, is performed via the first dipole.Type: ApplicationFiled: July 2, 2020Publication date: January 7, 2021Inventors: Thierry Legay, Rafael Cordero Alvarez, Delphine Feuerstein
-
Publication number: 20210001137Abstract: A subcutaneous cardiac defibrillation system implantable comprising a housing and a subcutaneous implantable lead comprising a proximal end connected to the housing and a distal free end. The subcutaneous implantable lead comprises at least one defibrillation electrode and at least three detection electrodes. The first detection electrode and the second detection electrode form a first dipole, and the third detection electrode and the first detection electrode, or the third detection electrode and the second detection electrode, or the housing and one of said detection electrodes, form a second dipole. The defibrillation electrode is positioned between the second detection electrode and the third detection electrode, the first dipole is positioned between the housing and the defibrillation electrode, the third electrode is positioned between the free distal end of the lead and the defibrillation electrode, and the length of the first dipole is shorter than the length of the second dipole.Type: ApplicationFiled: July 2, 2020Publication date: January 7, 2021Inventors: Thierry Legay, Rafael Cordero Alvarez, Delphine Feuerstein
-
Patent number: 10869709Abstract: A cryosurgery system for application of medical-grade liquid nitrogen to a treatment area via a small, low pressure, open tipped catheter. The system includes a console, including a touch panel computer, a cryogen module, a suction module and an electronics module, and a disposable spray kit. Features include optional low cryogen flow setting to reduce the cryogen flow rate by 50%, improved cryogen flow consistency reducing pressure pulses and peaks, an integrated suction pump for improved consistency and self-checks, specified vent tube areas and corresponding maximum expected pressures during cryospray procedure; optional pressure sensing capability to monitor pressure during a treatment, and novel catheter designs of multilayer and flexible construction providing a variety of spray patterns.Type: GrantFiled: October 25, 2017Date of Patent: December 22, 2020Assignee: CSA Medical, Inc.Inventors: Ron Burr, Rafael Cordero, Marc Davidson, Wendelin Maners, Janel Petrilli
-
Patent number: 10849824Abstract: A blood storage container for the anaerobic storage of blood, having enhanced sealing methods and materials for the preservation of stored blood is provided.Type: GrantFiled: September 19, 2017Date of Patent: December 1, 2020Assignee: Hemanext Inc.Inventors: Tatsuro Yoshida, Rafael Cordero, Jancarlo Sarita, Michael Zocchi, Michael Wolf, Philip Michael Keegan, Narendran Renganathan, Jeffrey Karl Sutton
-
Patent number: D961765Type: GrantFiled: July 11, 2018Date of Patent: August 23, 2022Assignee: Hemanext Inc.Inventors: Janearlo Sarita, Rafael Cordero, Jeffrey Sutton, Michael Zocchi, Ayan Bhandari, David Copeland